genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
05 December 2024
Annual Report and Accounts 2024
View all reports >
Friday May 30, 2025
Genedrive wins EU approval for genetic test used in stroke care
Tuesday May 13, 2025
Genedrive test kits set for new NHS trial in Manchester
Tuesday August 06, 2024
genedrive shares down 10% after CEO departure
View all news >
This site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.
Don't show this again